Literature DB >> 17031774

[The predictive quality of the Psychopathy Checklist-Revised (PCL-R) for violent and sex offenders in Switzerland. A validation study].

F Urbaniok1, T Noll, A Rossegger, J Endrass.   

Abstract

In Switzerland, the Hare Psychopathy Checklist-Revised (PCL-R) is administered rather restrictively for risk assessment of recidivism among violent and sexual offenders. The aim of the present study was a first-time evaluation of the predictive validity of the PCL-R for violent and sexual recidivism in Switzerland. The PCL-R scores of 96 violent and sex offenders were evaluated by collecting the data in their psychiatric expert opinions. The scores were then compared to the rates of recidivism as shown in the criminal records. Consistent with previous studies in North America and Europe, the determined predictive accuracy was satisfying. This degree of precision supports the use of the PCL-R for risk assessment of sexual and violent recidivism in Switzerland, as long as the instrument does not constitute the sole criterion to determine future recidivism, but is applied only in combination with a thorough clinical evaluation. The use of precise cut-off scores did not prove to be a valid criterion for the prognosis of recidivism and can therefore not be recommended for Swiss offenders.

Entities:  

Mesh:

Year:  2006        PMID: 17031774     DOI: 10.1055/s-2006-932203

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  2 in total

1.  The prediction of criminal recidivism: the implication of sampling in prognostic models.

Authors:  Frank Urbaniok; Jérôme Endrass; Astrid Rossegger; Thomas Noll; William T Gallo; Jules Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-09-14       Impact factor: 5.270

2.  Predicting violent infractions in a Swiss state penitentiary: a replication study of the PCL-R in a population of sex and violent offenders.

Authors:  Jérôme Endrass; Astrid Rossegger; Frank Urbaniok; Arja Laubacher; Stefan Vetter
Journal:  BMC Psychiatry       Date:  2008-09-08       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.